Related Experiment Video
Updated: Nov 24, 2025
12:19
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
Published on: June 7, 2024
1.7K
Cancer: defeating the immortal
1INSERM, U898, Villejuif, France, Institut Gustave Roussy, Villejuif, France, Université Paris-Sud, Villejuif, France. kroemer@igr.fr
Cancer Biology & Therapy
|September 11, 2007
Summary
This reflection piece shares personal insights on a career in cancer biology and therapy at age 46. It offers a candid conversation about convictions, dilemmas, and future aspirations in the field.
Area of Science:
- Cancer Biology
- Therapeutic Research
Background:
- A personal reflection on a career in cancer research and therapy.
- The author, at 46, contemplates their professional journey and legacy.
Discussion:
- Sharing intimate convictions and professional dilemmas.
- A candid conversation about experiences and future outlook in cancer research.
Key Insights:
- Personal reflections on a career in cancer biology and therapy.
- Balancing past experiences with future aspirations in scientific endeavors.
Outlook:
- Future plans and ongoing research directions in cancer biology.
- Continued contributions to therapeutic advancements and understanding cancer.
More Related Videos
Related Concept Videos
02:18Cancer
52.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
52.3K
02:40Cancer Stem Cells and Tumor Maintenance
5.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.3K
02:15Replicative Cell Senescence
4.1K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.1K
02:53Adaptive Mechanisms in Cancer Cells
6.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.2K
02:12What is Cancer?
12.7K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
12.7K
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K